Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion-Reference-Cited by-同舟云学术

Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion

Published:2016-07-01 Issue:8 Volume:13 Page:2787-2795
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Chen Yuejie¹,Wang Shujing¹,Wang Shan¹,Liu Chengyu¹,Su Ching²,Hageman Michael²,Hussain Munir³,Haskell Roy⁴,Stefanski Kevin²,Qian Feng¹

Affiliation:

1. School of Pharmaceutical Sciences and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Tsinghua University, Beijing 100084, China

2. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Lawrenceville, New Jersey 08648, United States

3. Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, New Jersey 08903, United States

4. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492, United States

Funder

National Natural Science Foundation of China

Central Committee of the Communist Party of China

Bristol-Myers Squibb Company

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link